News >

Frontline Combos Significantly Improve Outcomes in Multiple Myeloma

Kristi Rosa
Published: Monday, Jul 08, 2019

Anastasios Raptis, MD

Anastasios Raptis, MD

The emergence of novel combinations in the frontline setting of multiple myeloma said led to significant survival gains, according to Anastasios Raptis, MD. Now, researchers are investigating if other promising approaches being explored in later lines of therapy, such as CAR T-cell therapy and bispecific T-cell engagers (BiTEs), could also be beneficial if moved upfront.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x